AIIMS Bhubaneswar is set to be designated as a Centre of Excellence (CoE) for the management and research of Sickle ...

Bhubaneswar: AIIMS Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for the management and research ...

AIIMS Bhubaneswar treats more than 700 registered Sickle Cell Patients, more than 500 patients are in the age group of 0-19-         Union Minister participates in a review meeting and scientific ...

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of ...

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II trial has recently been ...

The Key Congenital Adrenal Hyperplasia Companies in the market include - Neurocrine Biosciences, Spruce Biosciences, Neurocrine Bioscience, BridgeBio Pharma, Crinetics Pharmaceuticals Inc., Spruce ...

Lu AG13909 is a novel, humanised monoclonal antibody, under investigation for the treatment of patients with Congenital adrenal hyperplasia (CAH), a rare genetic disease.

Classic congenital adrenal hyperplasia, more commonly called classic CAH, is when there is an enzyme missing in the adrenal gland, which causes the body to have the inability to make enough cortisol.

The bond market has been getting a lot of attention lately, as the U.S. wrestles with its debt ceiling and Congress works on passing a big tax-and-spending bill. The U.S. has the world’s deepest ...